NLRP3 signaling in macrophages drives the differentiation of CD4+ T cells into tumor-promoting Th2, Th17, and T-regulatory cell types, while suppressing Th1 cell polarization and cytotoxic CD8+ T cell activation. The gene discussed is CD4; the disease is neoplasm.